Your browser doesn't support javascript.
loading
Proteomic and transcriptomic profiling of brainstem, cerebellum and olfactory tissues in early- and late-phase COVID-19.
Radke, Josefine; Meinhardt, Jenny; Aschman, Tom; Chua, Robert Lorenz; Farztdinov, Vadim; Lukassen, Sören; Ten, Foo Wei; Friebel, Ekaterina; Ishaque, Naveed; Franz, Jonas; Huhle, Valerie Helena; Mothes, Ronja; Peters, Kristin; Thomas, Carolina; Schneeberger, Shirin; Schumann, Elisa; Kawelke, Leona; Jünger, Julia; Horst, Viktor; Streit, Simon; von Manitius, Regina; Körtvélyessy, Péter; Vielhaber, Stefan; Reinhold, Dirk; Hauser, Anja E; Osterloh, Anja; Enghard, Philipp; Ihlow, Jana; Elezkurtaj, Sefer; Horst, David; Kurth, Florian; Müller, Marcel A; Gassen, Nils C; Melchert, Julia; Jechow, Katharina; Timmermann, Bernd; Fernandez-Zapata, Camila; Böttcher, Chotima; Stenzel, Werner; Krüger, Elke; Landthaler, Markus; Wyler, Emanuel; Corman, Victor; Stadelmann, Christine; Ralser, Markus; Eils, Roland; Heppner, Frank L; Mülleder, Michael; Conrad, Christian; Radbruch, Helena.
Afiliación
  • Radke J; Institute of Pathology, Universitätsmedizin Greifswald, Greifswald, Germany. josefine.radke@med.uni-greifswald.de.
  • Meinhardt J; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Berlin, Germany. josefine.radke@med.uni-greifswald.de.
  • Aschman T; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Chua RL; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Farztdinov V; Center of Digital Health, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Lukassen S; Core Facility High Throughput Mass Spectrometry, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Ten FW; Center of Digital Health, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Friebel E; Center of Digital Health, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Ishaque N; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Franz J; Center of Digital Health, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Huhle VH; Department of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.
  • Mothes R; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Peters K; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Thomas C; Institute of Pathology, Universitätsmedizin Greifswald, Greifswald, Germany.
  • Schneeberger S; Department of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.
  • Schumann E; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Kawelke L; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Jünger J; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Horst V; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Streit S; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • von Manitius R; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Körtvélyessy P; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Vielhaber S; Department of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Reinhold D; Department of Neurology, Otto von Guerike University Magdeburg, Magdeburg, Germany.
  • Hauser AE; Institute of Molecular and Clinical Immunology, Otto von Guerike University Magdeburg, Magdeburg, Germany.
  • Osterloh A; Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Enghard P; Immune Dynamics, Deutsches Rheuma-Forschungszentrum, a Leibniz Institute, Berlin, Germany.
  • Ihlow J; Department of Pathology, University Medical Center Ulm, Ulm, Germany.
  • Elezkurtaj S; Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Horst D; Department of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Kurth F; Department of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Müller MA; Department of Pathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Gassen NC; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Melchert J; Institute of Virology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Jechow K; Department of Psychiatry and Psychotherapy, University Hospital Bonn, Bonn, Germany.
  • Timmermann B; Institute of Virology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Fernandez-Zapata C; Center of Digital Health, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Böttcher C; Max Planck Institute for Molecular Genetics, Berlin, Germany.
  • Stenzel W; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Krüger E; Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Landthaler M; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Wyler E; Institute of Medical Biochemistry and Molecular Biology, Universitätsmedizin Greifswald, Greifswald, Germany.
  • Corman V; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
  • Stadelmann C; Institut für Biologie, Humboldt Universität, Berlin, Germany.
  • Ralser M; Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
  • Eils R; Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Heppner FL; German Centre for Infection Research (DZIF), associated partner, Berlin, Germany.
  • Mülleder M; Department of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.
  • Conrad C; Core Facility High Throughput Mass Spectrometry, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Radbruch H; Center of Digital Health, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
Nat Neurosci ; 27(3): 409-420, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38366144
ABSTRACT
Neurological symptoms, including cognitive impairment and fatigue, can occur in both the acute infection phase of coronavirus disease 2019 (COVID-19) and at later stages, yet the mechanisms that contribute to this remain unclear. Here we profiled single-nucleus transcriptomes and proteomes of brainstem tissue from deceased individuals at various stages of COVID-19. We detected an inflammatory type I interferon response in acute COVID-19 cases, which resolves in the late disease phase. Integrating single-nucleus RNA sequencing and spatial transcriptomics, we could localize two patterns of reaction to severe systemic inflammation, one neuronal with a direct focus on cranial nerve nuclei and a separate diffuse pattern affecting the whole brainstem. The latter reflects a bystander effect of the respiratory infection that spreads throughout the vascular unit and alters the transcriptional state of mainly oligodendrocytes, microglia and astrocytes, while alterations of the brainstem nuclei could reflect the connection of the immune system and the central nervous system via, for example, the vagus nerve. Our results indicate that even without persistence of severe acute respiratory syndrome coronavirus 2 in the central nervous system, local immune reactions are prevailing, potentially causing functional disturbances that contribute to neurological complications of COVID-19.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans Idioma: En Revista: Nat Neurosci Asunto de la revista: NEUROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Base de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans Idioma: En Revista: Nat Neurosci Asunto de la revista: NEUROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Alemania